Magdalena Karetko-Sysa

Magdalena Karetko-Sysa serves as the Director of Feasibility Analytics and Strategy Lead for Oncology at Pfizer since May 2020, where responsibilities include leading Site Intelligence efforts, optimizing site footprint strategies, and collaborating with Clinical Operations to enhance site selection processes across clinical programs. Previously, Magdalena held various roles at PAREXEL from October 2012 to April 2020, including Associate Director and Clinical Feasibility Leader, and contributed as a Research Assistant at the Nencki Institute of Experimental Biology for a brief period in 2012. Magdalena earned a Ph.D. in Neurobiology and Neurosciences from the Nencki Institute of Experimental Biology in 2012 and a Master’s Degree in Biology with a specialization in cytology from Jagiellonian University in 2007.